Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Zentalis Pharma Posts Q3 2026 10-Q With 98.3M Shares Out

Zentalis Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing financial results, operational updates, and risk factors for the quarter.

Nitish Kishor | 09 November 2026

Kemper Q3 2026 Earnings Results Released November 9

Kemper Corporation filed a Form 8-K on November 9, 2026, announcing the release of its financial results for the third quarter of 2026 along with the availability of an investor supplement and earnings call presentation on its website.

Manish Choudhary | 09 November 2026

ADC Therapeutics Files Q3 2026 Form 10-Q with 140.7M Shares

ADC Therapeutics SA (NYSE:ADCT) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, covering the company's financial condition and operations through the third quarter.

Anjali Anand | 09 November 2026

Redwood Trust Q3 2026: Net Loss Widens to $45.5M

Redwood Trust, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a net loss of $45.5 million for the third quarter and total assets of approximately $30.4 billion.

Vinay Lochav | 09 November 2026

Clearway Energy Q3 2026 10-Q: Shares and Senior Notes

Clearway Energy, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the period ended September 30, 2026, and disclosing share counts, debt structure, and a completed solar portfolio acquisition.

Aditi Sarkar | 09 November 2026

MARA Holdings Q3 2026: $632M Net Income, $1.24B Nine-Month Loss

MARA Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting a net income of $632.071 million for the third quarter alongside a net loss of $1.241643 billion for the nine months …

Anjali Anand | 09 November 2026

Occidental Petroleum Q3 2026: Net Sales Rise to $6.57B

Occidental Petroleum Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting continued operations following the January 2026 close of its OxyChem divestiture.

Vinay Lochav | 09 November 2026

Attovia ATTO-1310 Phase 1b Topline 12-Week Results

Attovia Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing positive topline 12-week results from its Phase 1b study of ATTO-1310 in patients with chronic pruritus and high-itch atopic dermatitis, alongside a report of its third-quarter 2026 financial results.

Nitish Kishor | 09 November 2026

Myomo Q3 2026: Revenue Rises to $12.3M, Deficit Widens

Myomo, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the three and nine months ended September 30, 2026, disclosing revenue growth alongside a widening accumulated deficit and reduced cash position.

Aakashdeep | 09 November 2026

Rocket Lab Files 10-Q for Quarter Ended September 30, 2026

Rocket Lab Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the fiscal quarter ended September 30, 2026.

Anjali Anand | 09 November 2026
Support

Hi! How can we help you today?

Loading…